-
Elbasvir/grazoprevir, sold
under the
brand name Zepatier, is a fixed-dose
combination for the
treatment of
hepatitis C,
containing elbasvir (an inhibitor...
-
Elbasvir is a drug
approved by the FDA in
January 2016 for the
treatment of
hepatitis C. It was
developed by
Merck and
completed Phase III trials, used...
- or 12 w****s of
elbasvir/grazoprevir, ledipasvir/sofosbuvir, or sofosbuvir/velpatasvir. An
alternative treatment regimen of
elbasvir/grazoprevir with...
- a
number of
pharmaceutical drugs including, for example, apararenone,
elbasvir, and etifoxine. Polybenzoxazines, also
called benzoxazine resins, are a...
- trials, used in
combination with the NS5A
replication complex inhibitor elbasvir under the
trade name Zepatier,
either with or
without ribavirin. Grazoprevir...
-
Asunaprevir J05AP07
Daclatasvir J05AP08
Sofosbuvir J05AP09
Dasabuvir J05AP10
Elbasvir J05AP11
Grazoprevir J05AP12
Coblopasvir J05AP13
Ravidasvir J05AP14 Narlaprevir...
- with ABT-530, and
grazoprevir in
combination with
elbasvir, of
which velpatasvir, ABT-530 and
elbasvir are NS5A inhibitors. NS5A
Hepatitis C
Protease inhibitor...
- velpatasvir)
Vosevi (sofosbuvir, velpatasvir, and voxilaprevir)
Zepatier (
elbasvir and grazoprevir)
Mavyret (glecaprevir and pibrentasvir) The
United States...
- led the
development of
antivirals for
Hepatitis C
Virus (HCV)
including Elbasvir and Grazoprevir. She
currently serves as Vice
President for Infectious...
-
individuals with HIV/HCV co-infection as
those with HCV mono-infection:
Elbasvir/Grazoprevir The
Phase 3, open-label, single-arm C-EDGE CO-INFECTION Study...
